tiprankstipranks
Peptidream Inc. (PPTDF)
OTHER OTC:PPTDF
US Market

Peptidream (PPTDF) Stock Forecast & Price Target

20 Followers
See the Price Targets and Ratings of:

PPTDF Analyst Ratings

Moderate Buy
2Ratings
Moderate Buy
1 Buy
1 Hold
0 Sell
Based on 2 analysts giving stock ratings to
Peptidream
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PPTDF Stock 12 Month Forecast

Average Price Target

$11.95
▲(1.72% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Peptidream in the last 3 months. The average price target is $11.95 with a high forecast of $17.16 and a low forecast of $6.74. The average price target represents a 1.72% change from the last price of $11.75.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","18":"$18","8.25":"$8.25","11.5":"$11.5","14.75":"$14.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17.1612,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.951550000000001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.95</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.7419,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$6.74</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,8.25,11.5,14.75,18],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.16,7.0062461538461545,7.852492307692308,8.698738461538461,9.544984615384616,10.39123076923077,11.237476923076922,12.083723076923077,12.929969230769231,13.776215384615385,14.62246153846154,15.468707692307692,16.31495384615385,{"y":17.1612,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.16,6.605503846153846,7.051007692307692,7.496511538461538,7.9420153846153845,8.38751923076923,8.833023076923077,9.278526923076925,9.724030769230769,10.169534615384617,10.615038461538461,11.060542307692309,11.506046153846155,{"y":11.951550000000001,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.16,6.204761538461539,6.249523076923077,6.2942846153846155,6.339046153846154,6.383807692307692,6.428569230769231,6.4733307692307696,6.518092307692308,6.562853846153846,6.607615384615385,6.652376923076924,6.6971384615384615,{"y":6.7419,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":13.18,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":10.66,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":11.1,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":11.07,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.79,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.94,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.48,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.42,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.99,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.69,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.02,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.16,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$17.16Average Price Target$11.95Lowest Price Target$6.74
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
$6.74
Hold
-42.62%
Downside
Reiterated
07/22/26
Analysts Offer Insights on Healthcare Companies: Celldex (NASDAQ: CLDX), Bristol-Myers Squibb (NYSE: BMY) and Peptidream (Other OTC: PPTDF)
Goldman Sachs Analyst forecast on PPTDF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$17.16
Buy
46.05%
Upside
Reiterated
07/17/26
Goldman Sachs Sticks to Its Buy Rating for Peptidream (PPTDF)
SBI Securities Analyst forecast on PPTDF
Unknown Analyst
SBI Securities
Not Ranked
SBI Securities
$22.06$19.61
Buy
66.92%
Upside
Reiterated
03/02/26
SBI Securities Reaffirms Their Buy Rating on Peptidream (PPTDF)
Nomura Analyst forecast on PPTDF
Unknown Analyst
Nomura
Not Ranked
Nomura
$16.55
Buy
40.84%
Upside
Reiterated
02/17/26
Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)
SMBC Nikko Analyst forecast on PPTDF
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
$16.55
Buy
40.84%
Upside
Reiterated
12/10/25
Mizuho Securities Analyst forecast on PPTDF
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$26.97
Buy
129.51%
Upside
Reiterated
12/09/25
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi
$6.74
Hold
-42.62%
Downside
Reiterated
07/22/26
Analysts Offer Insights on Healthcare Companies: Celldex (NASDAQ: CLDX), Bristol-Myers Squibb (NYSE: BMY) and Peptidream (Other OTC: PPTDF)
Goldman Sachs Analyst forecast on PPTDF
Unknown Analyst
Goldman Sachs
Not Ranked
Goldman Sachs
$17.16
Buy
46.05%
Upside
Reiterated
07/17/26
Goldman Sachs Sticks to Its Buy Rating for Peptidream (PPTDF)
SBI Securities Analyst forecast on PPTDF
Unknown Analyst
SBI Securities
Not Ranked
SBI Securities
$22.06$19.61
Buy
66.92%
Upside
Reiterated
03/02/26
SBI Securities Reaffirms Their Buy Rating on Peptidream (PPTDF)
Nomura Analyst forecast on PPTDF
Unknown Analyst
Nomura
Not Ranked
Nomura
$16.55
Buy
40.84%
Upside
Reiterated
02/17/26
Nomura Sticks to Their Buy Rating for Peptidream (PPTDF)
SMBC Nikko Analyst forecast on PPTDF
Unknown Analyst
SMBC Nikko
Not Ranked
SMBC Nikko
$16.55
Buy
40.84%
Upside
Reiterated
12/10/25
Mizuho Securities Analyst forecast on PPTDF
Unknown Analyst
Mizuho Securities
Not Ranked
Mizuho Securities
$26.97
Buy
129.51%
Upside
Reiterated
12/09/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ZVRAZevra Therapeutics
KURAKura Oncology
GKOSGlaukos
AHCOAdaptHealth
VTVTvTv Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Peptidream

3 Months
Akinori UedaGoldman Sachs
Success Rate
0/4 ratings generated profit
0%
Average Return
-18.43%
Copying Akinori Ueda's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -18.43% per trade.
1 Year
Akinori UedaGoldman Sachs
Success Rate
0/4 ratings generated profit
0%
Average Return
-42.60%
Copying Akinori Ueda's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -42.60% per trade.
2 Years
Akinori UedaGoldman Sachs
Success Rate
0/4 ratings generated profit
0%
Average Return
-48.90%
Copying Akinori Ueda's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -48.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PPTDF Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
3
3
1
0
1
Buy
0
0
0
0
0
Hold
1
1
1
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
2
0
2
In the current month, PPTDF has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. PPTDF average Analyst price target in the past 3 months is 11.95.
Each month's total comprises the sum of three months' worth of ratings.

PPTDF Financial Forecast

PPTDF Earnings Forecast

Next quarter’s earnings estimate for PPTDF is -$0.02 with a range of -$0.02 to -$0.02. The previous quarter’s EPS was -$0.04. PPTDF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year PPTDF has Performed in-line its overall industry.
Next quarter’s earnings estimate for PPTDF is -$0.02 with a range of -$0.02 to -$0.02. The previous quarter’s EPS was -$0.04. PPTDF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year PPTDF has Performed in-line its overall industry.

PPTDF Sales Forecast

Next quarter’s sales forecast for PPTDF is $34.65M with a range of $34.65M to $34.65M. The previous quarter’s sales results were $29.09M. PPTDF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year PPTDF has Performed in-line its overall industry.
Next quarter’s sales forecast for PPTDF is $34.65M with a range of $34.65M to $34.65M. The previous quarter’s sales results were $29.09M. PPTDF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year PPTDF has Performed in-line its overall industry.

PPTDF Stock Forecast FAQ

What is PPTDF’s average 12-month price target, according to analysts?
Based on analyst ratings, Peptidream Inc.’s 12-month average price target is 11.95.
    What is PPTDF’s upside potential, based on the analysts’ average price target?
    Peptidream Inc. has 1.72% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PPTDF a Buy, Sell or Hold?
          Peptidream Inc. has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Peptidream Inc.’s price target?
            The average price target for Peptidream Inc. is 11.95. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $17.16 ,the lowest forecast is $6.74. The average price target represents 1.72% Increase from the current price of $11.75.
              What do analysts say about Peptidream Inc.?
              Peptidream Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
                How can I buy shares of PPTDF?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.